Pancreatic Cancer Awareness Month: Know the Signs, Understand Your Risk and Explore Treatment Options
November is Pancreatic Cancer Awareness Month, a time to raise awareness about one of the most challenging cancers to detect early, recognize potential warning signs and highlight advances in cancer research and treatment.
Pancreatic cancer develops when abnormal cells in the pancreas begin to grow uncontrollably. Because the pancreas is located deep within the abdomen and early symptoms may be absent or difficult to recognize, the disease is often diagnosed after it has progressed.
Understanding the risk factors, knowing which symptoms to watch for and discussing persistent health changes with a healthcare provider are important steps toward making informed decisions about your health.
At Tennessee Cancer Specialists, our oncology team provides personalized cancer care for patients throughout East Tennessee. With full-time offices and satellite locations across the region, our team is committed to helping patients understand their diagnosis, explore treatment options and navigate their cancer journey with compassionate support.
What Is Pancreatic Cancer?
The pancreas is an organ located behind the stomach. It plays an important role in digestion by producing enzymes that help break down food. It also produces hormones, including insulin, that help regulate blood sugar.
Pancreatic cancer occurs when abnormal cells in the pancreas grow and multiply uncontrollably. There are several types, but the two broad categories are exocrine pancreatic cancers and pancreatic neuroendocrine tumors.
Pancreatic adenocarcinoma is the most common type. It typically develops in the cells lining the ducts that carry digestive enzymes from the pancreas.
Pancreatic neuroendocrine tumors are less common and develop from hormone-producing cells. These tumors can behave differently from the more common forms of pancreatic cancer, so an accurate diagnosis is essential for determining treatment.
Recognizing the Symptoms of Pancreatic Cancer
One of the challenges of pancreatic cancer is that it often does not cause noticeable symptoms in its early stages. When symptoms develop, they can resemble those of other health conditions.
Potential pancreatic cancer symptoms include:
- Abdominal pain that may spread to the back
- Unexplained weight loss
- Loss of appetite
- Yellowing of the skin or whites of the eyes, known as jaundice
- Dark urine or unusually light-colored stools
- Persistent fatigue or weakness
- Nausea or vomiting
- Digestive changes, including bloating
- New-onset diabetes or unexpected changes in blood sugar
These symptoms do not necessarily indicate pancreatic cancer. Many other conditions can cause similar problems. However, persistent, unexplained or worsening symptoms should be evaluated by a healthcare professional.
Jaundice, particularly when accompanied by dark urine or pale stools, warrants prompt medical evaluation.
Understanding Pancreatic Cancer Risk Factors
Pancreatic cancer can affect people with or without known risk factors. However, certain factors may increase the likelihood of developing the disease.
Age
The risk of pancreatic cancer generally increases with age. Although it is more common in older adults, it can also occur in younger people.
Smoking and Tobacco Use
Smoking is one of the most important modifiable risk factors for pancreatic cancer. Tobacco use can damage cells and contribute to changes that lead to cancer.
Quitting smoking can help reduce risk and provides other important health benefits.
Family History and Genetics
Having close relatives with pancreatic cancer may increase your risk. Certain inherited genetic changes, including mutations in BRCA1, BRCA2, PALB2 and other genes, can also increase risk.
People with a strong family history of pancreatic cancer or certain related cancers may benefit from discussing genetic counseling with their healthcare provider.
Diabetes
Diabetes is associated with an increased risk of pancreatic cancer. In some cases, newly developed diabetes can also be an early sign of the disease, particularly when it occurs alongside other unexplained symptoms.
Most people with diabetes will not develop pancreatic cancer. However, unexpected changes in blood sugar or new-onset diabetes without an obvious explanation should be discussed with a healthcare provider.
Chronic Pancreatitis
Chronic pancreatitis, a condition involving long-term inflammation of the pancreas, is associated with an increased risk of pancreatic cancer.
Excess Body Weight
Being overweight or having obesity is associated with an increased risk of pancreatic cancer. Maintaining a healthy weight, staying physically active and avoiding tobacco can support overall health and may help lower risk.
Having one or more risk factors does not mean you will develop pancreatic cancer. Likewise, people without known risk factors can still be diagnosed with the disease.
Can Pancreatic Cancer Be Detected Early?
Pancreatic cancer can be difficult to detect early because symptoms may not appear until the disease has progressed.
Unlike some other cancers, there is no standard screening test recommended for people at average risk who have no symptoms. Tests such as CT scans, MRI and endoscopic ultrasound may be used to evaluate people who have symptoms or certain high-risk conditions, but they are not recommended as routine screening for everyone.
People with a strong family history of pancreatic cancer or certain inherited genetic conditions may benefit from specialized risk assessment and surveillance.
If you believe you may be at increased risk, talk with your healthcare provider about whether genetic counseling or additional evaluation is appropriate.
How Is Pancreatic Cancer Diagnosed?
When pancreatic cancer is suspected, healthcare providers may recommend several tests to determine whether cancer is present and whether it has spread.
Diagnostic testing may include:
- Imaging tests: CT scans, MRI or other imaging studies can help identify abnormalities in the pancreas.
- Endoscopic ultrasound: This procedure uses an ultrasound device attached to an endoscope to produce detailed images of the pancreas.
- Biopsy: A tissue sample may be collected to examine cells for signs of cancer.
- Blood tests: Blood tests may provide information about overall health and liver function. Certain tumor markers, such as CA 19-9, may be used in evaluating or monitoring some patients, but they cannot independently diagnose pancreatic cancer.
- Genetic and molecular testing: Testing may identify inherited genetic changes or characteristics of the tumor that could influence treatment decisions.
An accurate diagnosis helps the oncology team determine the type of pancreatic cancer, its stage and which treatment options may be appropriate.
Pancreatic Cancer Treatment Options
Treatment for pancreatic cancer depends on several factors, including the type and stage of cancer, whether it can be surgically removed, molecular characteristics and the patient’s overall health.
Treatment options may include the following.
Surgery
For some patients whose cancer has not spread and can be safely removed, surgery may offer the opportunity for long-term disease control. The type of surgery depends on the tumor’s location and extent.
Chemotherapy
Chemotherapy uses medications to destroy cancer cells or slow their growth. It may be recommended before surgery, after surgery or as the primary treatment for advanced disease.
Radiation Therapy
Radiation therapy uses high-energy radiation to target cancer cells. It may be considered in selected cases as part of a broader treatment plan.
Targeted Therapy
Some pancreatic cancers have genetic or molecular characteristics that may make them eligible for targeted treatments. Molecular testing can help identify these characteristics and determine whether a targeted medication may be appropriate.
Immunotherapy
Immunotherapy may be an option for a small subset of pancreatic cancers with specific biomarkers or molecular features. It is not effective for every patient, so testing and individualized evaluation are important.
Clinical Trials
Clinical trials evaluate new medications, treatment combinations and other approaches to cancer care. Eligible patients may have opportunities to participate in research exploring new options for pancreatic cancer.
Not every treatment is appropriate for every patient. An individualized treatment plan helps ensure that recommendations reflect the patient’s diagnosis, overall health and treatment goals.
The Importance of Personalized Cancer Care
A pancreatic cancer diagnosis can be overwhelming for patients and their families. Questions about treatment, side effects, nutrition, prognosis and next steps are common.
At Tennessee Cancer Specialists, our oncology team understands that each patient’s cancer journey is different. Treatment recommendations depend on the specific diagnosis, stage of disease, overall health and individual circumstances.
Our team is committed to helping patients understand their options and receive compassionate, personalized care throughout treatment.
Advances in Pancreatic Cancer Research
Cancer research continues to improve our understanding of pancreatic cancer and identify new approaches to treatment.
Researchers are studying targeted therapies, immunotherapies, combinations of existing medications and other innovative treatment strategies. Genetic and molecular testing is also helping physicians identify characteristics of certain tumors that may guide treatment decisions.
Tennessee Cancer Specialists offers access to clinical trials through the Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations.
Clinical trials are not appropriate for every patient, but your oncology team can help determine whether a study may be an option based on your diagnosis, previous treatments and individual circumstances.
What Can You Do During Pancreatic Cancer Awareness Month?
November is an opportunity to learn about pancreatic cancer, share reliable information and encourage conversations about risk and symptoms.
Consider taking these steps:
- Learn the potential warning signs of pancreatic cancer.
- Talk with your healthcare provider about persistent or unexplained symptoms.
- Discuss your family history of pancreatic cancer and related cancers.
- Ask about genetic counseling if you may have an increased inherited risk.
- Avoid tobacco use and seek support if you want to quit smoking.
- Learn about available treatment options and clinical research if you or a loved one receives a diagnosis.
Awareness cannot prevent every case of pancreatic cancer, but understanding the disease can help people recognize concerning changes and seek medical evaluation when needed.
Pancreatic Cancer Care Throughout East Tennessee
A pancreatic cancer diagnosis can bring many challenges, but patients and their families do not have to navigate the journey alone.
Tennessee Cancer Specialists provides personalized oncology and hematology care throughout East Tennessee, with full-time offices and satellite locations serving communities across the region.
Our full-time offices include:
- Knoxville: Dowell Springs and Parkwest
- Greeneville
- Johnson City
- Kingsport
- Morristown
- Powell
- Harrogate
Our satellite offices include:
- Athens
- Downtown Regional in Knoxville
- Jefferson City Memorial Hospital
- Jefferson City–Summit
- LaFollette
- Newport
- Oak Ridge
- Sweetwater
- Turkey Creek in Knoxville
Satellite office schedules and services may vary. Visit the Tennessee Cancer Specialists locations page for addresses, contact information and current office details.
Our team is committed to providing individualized treatment planning, compassionate support and access to clinical research when appropriate. Through our partnership with the Sarah Cannon Research Institute, eligible patients may also have opportunities to explore clinical trials.
This Pancreatic Cancer Awareness Month, take time to learn the symptoms, understand your risk and talk with your healthcare provider about any health changes that concern you.
Awareness, timely medical evaluation and advances in cancer research all play important roles in the ongoing effort to improve outcomes for people affected by pancreatic cancer.